Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

2005172 citationsJournal Article

Authors

Good health and well-being

Published in: Gene Therapy

Volume 12, Issue 5, pp. 437-445

Field-Weighted Citation Impact: 9.41